Odevixibat Shows 'Encouraging Results' for Kids With Alagille Syndrome

(MedPage Today) -- WASHINGTON -- Treatment with odevixibat (Bylvay) led to early, rapid, and sustained improvements in pruritus among pediatric patients with Alagille syndrome, as well as reductions in bile acid levels, the phase III ASSERT trial...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news